Startups

Vice President, Clinical Development, Oncology

Xaira · South San Francisco, California, United States · On-site

← All jobs
About Xaira

We’re pioneering the discovery and development of life-changing medicines through the transformative power of artificial intelligence. Backed by Lightspeed, NEA and Sequoia.

About the role

Xaira Therapeutics is seeking a Vice President, Early Clinical Development to lead development of the company’s oncology portfolio as it advances from discovery into the clinic. Reporting to the Senior Vice President, Translational Science and Early Clinical Development, the Vice President will be accountable for clinical development strategy, IND-enabling clinical planning, first-in-human study design and execution, and the progression of priority programs through clinical proof of concept and into late-stage... Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • MD or MD/PhD required. Completion of residency and fellowship in medical oncology or hematology/oncology, with board certification, strongly preferred
  • A minimum of 12 years of clinical development experience in the biotechnology or pharmaceutical industry, including at least 5 years in a leadership capacity with accountability for programs and direct reports
  • Demonstrated oncology depth across more than one tumor type, with direct experience conducting dose-finding and dose-optimization studies in patients with advanced cancer
  • Extensive regulatory experience, including direct interaction with FDA and preferably EMA across IND or CTA submissions, End-of-Phase meetings, and expedited program pathways
  • Excellent written and verbal communication skills, with experience presenting to executive leadership, Boards of Directors, health authorities, and external scientific audiences
  • Demonstrated effectiveness in a fast-paced, resource-conscious environment requiring both strategic leadership and hands-on execution
More about this role

Xaira is an innovative biotech startup focused on leveraging AI to transform drug discovery and development. The company is leading the development of generative AI models to design protein and antibody therapeutics, enabling the creation of medicines against historically hard-to-drug molecular targets. It is also developing foundation models for biology and disease to enable better target elucidation and patient stratification. Collectively, these technologies aim to continually enable the identification of novel therapies and to improve success in drug development. Xaira is headquartered in the San Francisco Bay Area, Seattle, and London.

Xaira Therapeutics is seeking a Vice President, Early Clinical Development to lead development of the company’s oncology portfolio as it advances from discovery into the clinic. Reporting to the Senior Vice President, Translational Science and Early Clinical Development, the Vice President will be accountable for clinical development strategy, IND-enabling clinical planning, first-in-human study design and execution, and the progression of priority programs through clinical proof of concept and into late-stage development.

This is a founding...

Read the full posting on Xaira's site ↗

Clinical Development

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.